首页 >
法规速递
-
Document: Agenda - EnprEMA & ACT EU workshop on paediatric clinical trials-2026/5/5
2026-05-06查看详情 > -
Scientific guideline: ICH: Q5A(R2): Viral safety evaluation of biotechnology products derived from cell lines of human or animal origin - Step 2b-2022/10/10
2022-11-15查看详情 > -
国家药监局关于修订二氯醋酸二异丙胺注射剂（含复方二氯醋酸二异丙胺）说明书的公告 （2023年第52号）-2023/4/24
2023-04-25查看详情 > -
国家药监局关于发布《药物临床试验机构监督检查办法（试行）》的通告（2023年第56号）-2023/11/3
2023-11-06查看详情 > -
Document: Procedure for the preparation of European Union herbal monographs and European Union list entries and appointment of HMPC rapporteurs and peer-reviewers-2025/1/13
2025-01-14查看详情 > -
Document: Programme - EMA's Open Door Day-2025/2/18
2025-02-19查看详情 > -
Document: Decision of the European Medicines Agency on rules relating to Articles 11, 11a and 13 of the Staff Regulations concerning the handling of declared interests of staff members of the European Medicines Agency and candidates before recruitment-202
2025-03-27查看详情 > -
Document: EMA Agile governance model-2025/4/30
2025-05-06查看详情 > -
Document: Annex 10 - 2024 annual report of the European Medicines Agency – CHMP opinions on initial evaluations and extensions of therapeutic indication-2025/6/10
2025-06-11查看详情 > -
关于将KC1036片纳入《儿童抗肿瘤药物研发鼓励试点计划（星光计划）》试点项目的公示-2025/7/16
2025-07-17查看详情 >
